This document announces a conference on HPV infection among women with or at risk for HIV. It notes that HPV infection is common among HIV+ women and can lead to cervical cancer. While HAART has reduced AIDS, its effect on HPV and cervical dysplasia is unknown. The conference aims to investigate the role of HPV in HIV+ women and discuss treatment and prevention strategies like the HPV vaccine. Topics will include the epidemiology of HPV/HIV co-infection, treating cervical disease, updates on the HPV vaccine trial, and implementing HPV vaccination. The event is intended for physicians, PAs, NPs, and nurses providing care to HIV+ or at-risk women.